breast cancer

June 14, 2022
Elizabeth H. Dibble, MD; Stephanie L. Graff, MD, FACP; Theresa A. Graves, MD, FACS; and Chelsea J. Miller, MD

What Hodgkin Lymphoma Survivors Should Know About Mantle Radiation and Breast Cancer Risk

English
graff.dibble.graves.miller

In this post, several experts describe what Hodgkin lymphoma survivors who received mantle radiation should know about their increased breast cancer risk, including what to know about screening and monitoring for signs of breast cancer.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 7, 2022
Brielle Gregory Collins, ASCO staff

2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in People 55+ With Luminal A Breast Cancer

English
Brielle.Gregory.Collins

The ASCO Annual Meeting is being held June 3 to 7, and here is some of notable research that will be presented today. Today’s research includes a study evaluating whether radiation therapy can be avoided after surgery for people aged 55 or older with low-grade luminal A breast cancer, as identified through biomarker testing.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 5, 2022
Leslie Fannon Zhang, ASCO staff

2022 ASCO Annual Meeting: Advances in Treating Breast Cancer, Colorectal Cancer, Ewing Sarcoma, and Multiple Myeloma

English
Leslie.Fannon.Zhang

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 4, 2022
Brielle Gregory Collins, ASCO staff

2022 ASCO Annual Meeting: Targeted Therapy for Advanced HR-Positive, HER2-Negative Breast Cancer and Using Liquid Biopsy to Guide Treatment for Stage II Colon Cancer

English
Brielle.Gregory.Collins

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
May 26, 2022
Greg Guthrie, ASCO Staff

Reunión anual de la ASCO de 2022: Gasto en servicios sociales y supervivencia al cáncer, Concientización sobre ensayos clínicos en personas de raza negra con cáncer de mama, Equidad y telemedicina, y La supervivencia en el neuroblastoma

Spanish
Greg Guthrie

La Reunión Anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) de 2022 se llevará a cabo del 3 al 7 de junio. En esta publicación inicial de la investigación que se presenta en la reunión, los estudios examinan cómo la raza, el origen étnico, la pobreza y otros factores sociales y demográficos afectan la vida de las personas con cáncer.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
May 26, 2022
Greg Guthrie, ASCO Staff

2022 ASCO Annual Meeting: Social Services Spending and Cancer Survival, Clinical Trials Awareness Among Black People With Breast Cancer, Telemedicine Use During the Pandemic Is Not Equal, and Factors Affecting Survival in Neuroblastoma

English
Greg Guthrie

The 2022 ASCO Annual Meeting is being held June 3 to 7. In this early release of research being presented at the meeting, studies examine how race, ethnicity, poverty, and other social and demographic factors affect the lives of people with cancer.

Read More >>
May 24, 2022
ASCO Staff

What to Know About At-Home DNA Tests for Detecting Cancer Risk

English
ASCO.Staff

At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider.

Read More >>

Pages

Subscribe to RSS - breast cancer